Company newsCompany release

Medtronic MDT

Medtronic says it intends to acquire Contego Medical

Medtronic said the acquisition is valued at $380 million, with potential payments post-acquisition.

GetSignal 

Share
Download on the App StoreGet it on Google Play

Free on iOS and Android

On November 16, 2026, Medtronic said it intends to acquire Contego Medical, a privately held medical device company focused on carotid artery disease and peripheral thrombectomy. Medtronic said the acquisition builds on the exclusive U.S. distribution agreement the companies first announced in January 2025.

Medtronic said the acquisition includes the FDA-approved Neuroguard IEP Direct System, a transcarotid artery revascularization system with integrated embolic protection in addition to flow reversal, and the Excipio thrombectomy devices. Medtronic said the Excipio devices complement its Liberant thrombectomy system in treating peripheral vascular disease. Medtronic said that in the prospective, multicenter PERFORMANCE III study, the Neuroguard IEP Direct System recorded zero strokes, zero neurological deaths, zero cranial nerve injuries and zero myocardial infarctions at 30 days.

Medtronic said it expects to complete the transaction in the third quarter of its fiscal year, subject to customary closing conditions. David Moeller, senior vice president and president of Medtronic Peripheral Vascular Health, said Medtronic intends to strengthen its leadership in the treatment of carotid artery disease by pairing its peripheral and neurovascular technologies with Contego's treatments.

Key facts

Announced
November 16, 2026
Deal value, with potential payments post-acquisition, per Medtronic
$380 million
Expected completion
Third quarter of Medtronic's fiscal year, subject to customary closing conditions
Distribution agreement first announced
January 2025

All MDT news

Source: The company's release on PR Newswire, November 16, 2026.

Written by GetSignal with AI from the company's press release. How we make news

Not investment advice.

More company news

Medtronic first, then the newest
  1. Bruker appoints Eicke Latz to its board, effective January 1, 2027

    BRKR · Bruker · Form 8-K and release · Nov 16, 2026

All company news